Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-rhabdomyosarcoma Soft Tissue Sarcomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02945800
What this trial is testing

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

Who this might be right for
OsteosarcomaEwing SarcomaRhabdomyosarcoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 59
Testing effectiveness (Phase 2)Study completedNCT00002804
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more
National Cancer Institute (NCI) 1,377
Testing effectiveness (Phase 2)Active Not RecruitingNCT00840047
What this trial is testing

Methionine PET/CT Studies In Patients With Cancer

Who this might be right for
Brain Tumors and/or Solid Tumors IncludingBrain Stem GliomaHigh Grade CNS Tumors+11 more
St. Jude Children's Research Hospital 503
Testing effectiveness (Phase 2)Study completedNCT00520936
What this trial is testing

Pemetrexed in Children With Recurrent Cancer

Who this might be right for
OsteosarcomaMedulloblastomaSarcoma, Ewing's+6 more
Eli Lilly and Company 72
Not applicableStudy completedNCT00592293
What this trial is testing

Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas

Who this might be right for
Non-rhabdomyosarcoma Soft Tissue SarcomaBone Sarcoma
Massachusetts General Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00003408
What this trial is testing

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Cancer Treatment Centers of America 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213704
What this trial is testing

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Testing effectiveness (Phase 2)Study completedNCT03213665
What this trial is testing

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Non-Hodgkin Lymphoma+38 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00638898
What this trial is testing

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

Who this might be right for
Solid TumorAdult Central Nervous System Germ Cell TumorAdult Rhabdomyosarcoma+27 more
City of Hope Medical Center 25
Large-scale testing (Phase 3)Study completedNCT00346164
What this trial is testing

Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft-part SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma+26 more
Children's Oncology Group 588
Testing effectiveness (Phase 2)Study completedNCT03233204
What this trial is testing

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+33 more
National Cancer Institute (NCI) 6
Not applicableStudy completedNCT01567046
What this trial is testing

Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas

Who this might be right for
Childhood Alveolar Soft-part SarcomaChildhood AngiosarcomaChildhood Desmoplastic Small Round Cell Tumor+12 more
Children's Oncology Group 70
Early research (Phase 1)Enrolling By InvitationNCT03054792
What this trial is testing

Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas

Who this might be right for
RhabdomyosarcomaNon-Rhabdo. Soft Tissue Sarcoma
The Hospital for Sick Children 18
Post-approval studies (Phase 4)Study completedNCT04854018
What this trial is testing

Indo-cyanine Green (ICG) in Paediatric Oncology MIS

Who this might be right for
Pediatric Renal TumorMetastatic OsteosarcomaMetastatic Ewing Sarcoma+3 more
Birmingham Women's and Children's NHS Foundation Trust 20
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Early research (Phase 1)Study completedNCT02890758
What this trial is testing

Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeAcute Lymphoblastic Leukemia+11 more
Brenda Cooper, MD 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT02574728
What this trial is testing

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

Who this might be right for
Cancer
Emory University 46
Early research (Phase 1)Not Yet RecruitingNCT07224568
What this trial is testing

Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors

Who this might be right for
Solid Tumor (Excluding CNS)Hepatocellular CarcinomaLiver Cell Carcinoma+3 more
Seattle Children's Hospital 21
Next Page